Chemical Compound

Rubitecan

CAS Registry Number 91421-42-0
Rubitecan chemical structure
Primary Record

Rubitecan

In stock
9,712 g
Purity
99.0 %
CAS
91421-42-0

Compound Identifiers & Properties

CAS
91421-42-0
PubChem CID
472335
SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O
Canonical SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1

Names & Synonyms

  • Rubitecan
  • 9-Nitrocamptothecin
  • Orathecin
  • Camptogen
  • 91421-42-0
  • rubitecanum
  • Nitrocamptothecin
  • 9-nitro-20(S)-camptothecin
  • rubetican
  • 9-NC
  • Inhaled Orathecin
  • Rubitecan [USAN]
  • 9-Nitro-CPT
  • Rubitecan (inhaled)
  • RFS 2000
  • 9-nitro camptothecin
  • 9-Amino-camptothecin
  • RFS-2000
  • Rubitecan [USAN:INN]
  • AC1LAOVR
  • RUBITECAN [INN]
  • 9-nitro-(20S)-camptothecin
  • RUBITECAN [MI]
  • Rubitecan (USAN/INN)
  • L9NC
  • RefChem:883953
  • RFS2000
  • Camptothecin Impurity 13
  • H19C446XXB
  • UNII-H19C446XXB
  • 9-nitro-20-(S)-camptothecin
  • Ruboxistaurin Hydrochloride
  • DTXSID7046752
  • MFCD06656294
  • #NAME?
  • CHEBI:90225
  • D0I5XO
  • D0Y1FO
  • RUBITECAN [MART.]
  • RUBITECAN [WHO-DD]
  • SCHEMBL8640
  • 9-nitrocamptothecin, (S)-
  • C20H15N3O6
  • DTXCID5026752
  • RFS 2000;9-Nitrocamptothecin
  • 9-Nitrocamptothecin (9-NC)
  • ethyl-hydroxy-nitro-[?]dione
  • CHEMBL77305
  • 9-nitro-20(s)-camptothecine
  • Rubitecan (inhaled), SuperGen
  • AC1Q21R5
  • orb1301430
  • 86639-62-5
  • SCHEMBL29379605
  • SCHEMBL29383355
  • camptothecin, 9-nitro-20(s)-
  • CTK8B3048
  • 9-nitrocamptothecin, (S)-isomer
  • WLZ3809
  • VHXNKPBCCMUMSW-FQEVSTJZSA-N
  • BCP06207
  • EBD39671
  • EX-A4326
  • Rubitecan, 98% - 10MG 10mg
  • ZINC3827362
  • 9-nitrocamptothecin (rubitecan)
  • Tox21_112597
  • 3600AC
  • ABP001092
  • ANW-41681
  • AR-1H5905
  • BDBM50248354
  • CID472335
  • CN-061
  • NCGC00167969-01
  • NSC603070
  • s2288
  • AKOS015895332
  • AKOS025149224
  • C20-H15-N3-O6
  • (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • ACN-056771
  • CID:472335
  • DB06159
  • EBC-615615
  • FR27767
  • RL05757
  • ST-2617
  • KS-000017A1
  • NCGC00167969-02
  • NCGC00167969-03
  • AC-13389
  • AC-25083
  • AC-33157
  • AJ-45745
  • AS-14856
  • BC206171
  • BP-41442
  • HY-13744
  • M884
  • SC-54565
  • SID:53790631
  • SY078302
  • AB3000004
  • CAS-91421-42-0
  • J448.357J
  • LY 333531
  • TR-038378
  • CS-0007769
  • FT-0630977
  • N0822
  • ST24036187
  • D04031
  • 421R420
  • A847954
  • C079905
  • Q510113
  • (S)-4-Ethyl-4-hydroxy-9-nitro-1H-pyrano[3',4'
  • Aerosolized liposomal 9 nitro-20 (S) camptothecin
  • I06-2270
  • BRD-K79821389-001-01-9
  • BRD-K79821389-001-03-5
  • (s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
  • 9NC
  • B2692-079493
  • (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
  • (4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
  • 104195-61-1
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-
  • 4-Ethyl-4-hydroxy-9-nitro-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • 9-NC, 9-Nitro-camptothecin, Partaject Orathecin, Partaject rubitecan, RFS 2000
  • (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-10-Nitro-4-ethyl-4-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin; Orathecin
  • (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizinol[1,2-b]quinoline-3,14(4H,-12H)-dione
  • (4S)-4alpha-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4alpha-Ethyl-4-hydroxy-10-nitro-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4beta-Hydroxy-4-ethyl-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione Hydrochloride
  • (S)-4-ethyl-4-hydroxy-10-nitro-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
  • (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3\',4\':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 169939-93-9
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-
  • 4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 4|A-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
  • 4alpha-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 4alpha-Ethyl-4beta-hydroxy-10-nitro-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • 51-45-6
  • 87988-63-4
  • Rubitecan; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-, (4S)-